Sign in →

Test Code CRSY Chromium, Synovial Fluid


Specimen Required


Patient Preparation: High concentrations of gadolinium and iodine are known to interfere with most inductively coupled plasma mass spectrometry-based metal tests. If either gadolinium- or iodine-containing contrast media has been administered, a specimen should not be collected for at least 96 hours.

Supplies: Metal Free B-D Tube (EDTA), 6 mL (T183)

Container/Tube: Royal blue top (metal-free EDTA)

Specimen Volume: 1 mL

Collection Instructions: See Metals Analysis Specimen Collection and Transport for complete instructions.

Additional Information: Chromium is present in the black rubber plunger seals found in most disposable syringes. As a result, synovial fluid should not be collected in these devices as contamination may occur.


Useful For

Monitoring metallic prosthetic implant wear and local tissue destruction in failed hip arthroplasty constructs

 

This test is not useful for assessment of potential chromium toxicity.

Method Name

Inductively Coupled Plasma Mass Spectrometry (ICP-MS)

Reporting Name

Chromium, Synovial Fl

Specimen Type

Synovial Fluid

Specimen Minimum Volume

0.4 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Synovial Fluid Refrigerated (preferred) 90 days
  Ambient  90 days
  Frozen  90 days

Reject Due To

Gross hemolysis OK
Gross lipemia OK
Gross icterus OK

Clinical Information

Chromium (Cr) is a naturally-occurring element widely distributed in the environment. It exists in several valence states with the 3 main forms being Cr(0), Cr(III), and Cr(VI). Cr(III) is an essential trace element that enhances the action of insulin. Deficiency leads to impaired growth, reduced life span, corneal lesions, and alterations in carbohydrates, lipid, and protein metabolism.

 

Chromium is widely used in manufacturing processes to make various metal alloys, such as stainless steel. It is also used in many consumer products, including wood treated with copper dichromate, leather tanned with chromic sulfate, and metal-on-metal hip replacements.

 

Per US Food and Drug Administration recommendations, orthopedic surgeons should consider measuring and following serial chromium concentrations in EDTA anticoagulated whole blood in symptomatic patients with metal-on-metal hip implants as part of their overall clinical evaluation. However, a recent publication(1) has shown synovial fluid measurements were superior to whole blood and serum chromium concentrations in predicting local tissue destruction in failed hip arthroplasty constructs.

 

Prosthetic devices produced by Depuy Company, Dow Corning, Howmedica, LCS, PCA, Osteonics, Richards Company, Tricon, and Whiteside are typically made of chromium, cobalt, and molybdenum. This list of products is incomplete, and the products' compositions change occasionally; see each prostheses' product information for composition details.

 

The general population is most likely to be exposed to trace levels of chromium, as Cr(III) is naturally occurring in foods, such as fruits, vegetables, nuts, beverages, and meats. The highest potential occupational exposure occurs in the metallurgy and tanning industries, where workers may be exposed to high air concentrations. In cases of suspected toxicity, blood, serum, or urine concentrations of chromium can be checked.

Reference Values

0-17 years: Not established

≥18 years: <16.9 ng/mL

Interpretation

Based on an internal study, synovial fluid chromium concentrations of 16.9 ng/mL or above were more likely due to a metal reaction (eg, adverse local tissue reaction [ALTR]/adverse reaction to metal debris [ARMD]) versus a nonmetal reaction in patients undergoing metal-on-metal revision (sensitivity of 92.3% and specificity of 92.6%).

Cautions

This test is intended for monitoring of metallic prosthetic implant wear and should not be ordered to assess potential chromium toxicity.

 

Chromium is present in the environment at 100-fold to 1000-fold higher concentration than found in biological tissues. Reports of increased chromium could be due to external contamination. Metal-free blood collection procedures must be followed. Elevated trace element concentrations in the absence of corroborating clinical information do not independently predict prosthesis wear or failure.

 

This test should only be used in individuals with metallic prosthetic implants. The significance of chromium concentrations in synovial fluid in patients without implants is unknown.

Method Description

The metal of interest is analyzed by inductively coupled plasma mass spectrometry.(Unpublished Mayo method)

Day(s) Performed

Friday

Report Available

2 to 8 days

Specimen Retention Time

14 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

82495

LOINC Code Information

Test ID Test Order Name Order LOINC Value
CRSY Chromium, Synovial Fl 95526-0

 

Result ID Test Result Name Result LOINC Value
606353 Chromium, Synovial Fl 95526-0